teduglutide

FDA Drug Profile — Gattex

teduglutide is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand name including Gattex. Available dosage forms: injection, powder, lyophilized, for solution, kit, injection.

Drug details

Generic Name
teduglutide
Brand Names
Gattex
Application Number
NDA203441
Sponsor
Takeda Pharmaceuticals America, Inc.
NDC Codes
5
Dosage Forms
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, KIT, INJECTION
Routes
SUBCUTANEOUS
Active Ingredients
TEDUGLUTIDE

Indications and Usage

1 INDICATIONS AND USAGE GATTEX ® is indicated for the treatment of adults and pediatric patients 1 year of age and older with Short Bowel Syndrome (SBS) who are dependent on parenteral support . GATTEX ® is a glucagon-like peptide-2 (GLP-2) analog indicated for the treatment of adults and pediatric patients 1 year of age and older with Short Bowel Syndrome (SBS) who are dependent on parenteral support. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.